@article{Francis_A-2022_103545,
title = {Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination},
author = {Francis, A. and Elhadd, K. and Camera, V. and Ferreira Dos Santos, M. and Rocchi, C. and Adib-Samii, P. and Athwal, B. and Attfield, K. and Barritt, A. and Craner, M. and Fisniku, L. and Iversen, A. and Leach, O. and Matthews, L. and Redmond, I. and O'Riordan, J. and Scalfari, A. and Tanasescu, R. and Wren, D. and Huda, S. and Leite, M. and Fugger, L. and Palace, J.},
month = {nov},
year = {2022},
abstract = {BACKGROUND AND OBJECTIVES: Acute inflammatory CNS diseases include neuromyelitis optica spectrum disorders (NMOSDs) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Both MOGAD and acute disseminated encephalomyelitis (ADEM) have been reported after vaccination. Consequently, the mass SARS-CoV-2 vaccination program could result in increased rates of these conditions. We described the features of patients presenting with new acute CNS demyelination resembling NMOSDs or MOGAD within 8 weeks of SARS-CoV-2 vaccination.},
volume = {10},
issue = {1},
journal = {Neurology: Neuroimmunology and NeuroInflammation},
publisher = {Wolters Kluwer},
url = {https://doi.org/10.1212/NXI.0000000000200063},
}
